statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Lustgarten Foundation Appoints Two New Board Members

The Lustgarten Foundation Appoints Two New Board Members The Lustgarten Foundation Appoints Two New Board Members PR Newswire WOODBURY, N.Y., June 13, 2024 Richard Barakat, MD, and Aaron Kantoff join...

CNTA Stock Earnings: Centessa Pharmaceuticals Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips
CNTA stock results show that Centessa Pharmaceuticals beat analyst estimates for earnings per share the fourth quarter of 2023.
The post...

Centessa Pharmaceuticals PLC (CNTA) Earnings: A Detailed Look at Q4 and Full-Year 2023 Results

Aligning with EPS Projections, CNTA Reports a Net Loss Decrease in Q4Related Stocks: CNTA...

Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023

Hemophilia Program: Ongoing registrational PRESent-2 and PRESent-3 studies of SerpinPC for the treatment of hemophilia B; PRESent-2 advancing toward interim analysis planned in 2024Orexin Agonist...

Centessa Pharmaceuticals plc (CNTA, $11.1) entered Uptrend as Momentum indicator ascends above 0 level on Mar 27, 2024

This indicator may be signaling CNTA's price has momentum to move higher, since its current price moved above its price 14 days ago. Traders may consider buying the stock or exploring call options...

Centessa Pharmaceuticals PLC Chief People Officer Sells Company Shares

Centessa Pharmaceuticals plc (CNTA, $10.76) entered Downtrend as Momentum indicator drops below 0 level on Mar 26, 2024

This indicator may be signaling that CNTA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Centessa Pharmaceuticals plc (CNTA, $11.17) entered Uptrend as Momentum indicator ascends above 0 level on Mar 19, 2024

CNTA Crosses Above Average Analyst Target

In recent trading, shares of Centessa Pharmaceuticals PLC (CNTA) have crossed above the average analyst 12-month target price of 10.50, changing hands for 10.75/share. When a stock reaches...

Centessa Pharmaceuticals plc (CNTA, $10.47) entered Downtrend as Momentum indicator drops below 0 level on Mar 14, 2024

Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.

Volume	822,043.00
52-Wk High	$12.45
52-Wk Low	$5.15

CNTA Centessa Pharmaceuticals PLC - ADR

About

Feed

News

Sentiment

Earnings

Fundamentals